Table 3 Effect of KMP and/or 5-FU on liver function tests (A) and renal function tests (B).

From: Integrated blood and organ profile analysis to evaluate ameliorative effects of kaempferol on 5-fluorouracil-induced toxicity

Parameter

Control (0.9% Saline)

Control (0.5% CMC)

DMH

DMH/5-FU

DMH/KMP

DMH/5-FU(HD)/KMP

DMH/5-FU(LD)/KMP

(A) Liver function test

 Total bilirubin (mg/dL)

0.48 ± 0.02

0.48 ± 0.01

0.07 ± 0.01a

0.08 ± 0.02a

0.36 ± 0.02e,f

0.07 ± 0.01a,h

0.21 ± 0.05b,d,g

 SGPT/ALT (U/L)

38.4 ± 0.76

37.11 ± 3.13

64.65 ± 1.64b

98.8 ± 1.28c,e

28.35 ± 0.03a,d

33.31 ± 5.34b,g

59.3 ± 5.48b,g

 SGOT/AST (U/L)

98.3 ± 2.94

97.2 ± 1.15

165.5 ± 0.8a

205.85 ± 1.76b,d

67.9 ± 0.69e,f

109.93 ± 3.13 a,f,j

123.95 ± 4.08a,d,i

 ALP (U/L)

63.65 ± 0.25

63.2 ± 0.17

131.75 ± 25.72c

280.5 ± 23.07a,e

79.05 ± 6.26c,e

96.35 ± 8.13 d,f,i

83 ± 18.87 b,d,e,i

 GGT (U/L)

2.55 ± 0.49

2.6 ± 0.41

8.25 ± 1.84a

9.6 ± 1.84b

5.45 ± 0.37c,d,h

3.2 ± 1.21a,e,g

7.05 ± 0.21a,h

(B) Renal function test

 Urea (mg/dL)

32.93 ± 1.11

32.75 ± 0.89

43.52 ± 2.01a

48.35 ± 0.86b

41.96 ± 0.82

40.72 ± 0.81

41.42 ± 0.69

 BUN (mg/dL)

15.37 ± 0.52

15.41 ± 0.46

20.31 ± 1.41a

22.57 ± 1.61a

20.21 ± 0.75a

19.01 ± 0.38a

20.25 ± 0.86a

 Serum creatinine (mg/dL)

0.42 ± 0.06

0.43 ± 0.01

0.65 ± 0.02

1.09 ± 0.28a,d

0.46 ± 0.05

0.7 ± 0.04a,g

0.65 ± 0.02

  1. The values are represented as Mean ± SEM for n = 6 animals/ group.
  2. ap < 0.001w.r.t control group, bp < 0.01w.r.t control group, cp < 0.05w.r.t control group, dp < 0.001w.r.t DMH group, ep < 0.01w.r.t DMH group, fp < 0.001w.r.t DMH/5-FU group, gp < 0.01w.r.t DMH/5-FU group, hp < 0.05w.r.t DMH/5-FU group, ip < 0.01 w.r.t DMH/KMP group, jp < 0.05 w.r.t DMH/KMP group.